Robert Barrow
2023
In 2023, Robert Barrow earned a total compensation of $2.1M as Chief Executive Officer at Mind Medicine (MindMed), a 59% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $318,725 |
---|---|
Salary | $598,750 |
Stock Awards | $1,212,000 |
Other | $13,658 |
Total | $2,143,133 |
Barrow received $1.2M in stock awards, accounting for 57% of the total pay in 2023.
Barrow also received $318.7K in non-equity incentive plan, $598.8K in salary and $13.7K in other compensation.
Rankings
In 2023, Robert Barrow's compensation ranked 486th out of 3,006 executives tracked by ExecPay. In other words, Barrow earned more than 83.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 486 out of 3,006 | 84th |
Division Manufacturing | 280 out of 1,650 | 83rd |
Major group Chemicals And Allied Products | 193 out of 918 | 79th |
Industry group Drugs | 190 out of 881 | 78th |
Industry Medicinal Chemicals and Botanical Products | 4 out of 17 | 77th |
Source: SEC filing on April 26, 2024.
Barrow's colleagues
We found two more compensation records of executives who worked with Robert Barrow at Mind Medicine (MindMed) in 2023.